Back to Search Start Over

Determination of cannabinoids in human cerumen samples by use of UPLC-MS/MS as a potential biomarker for drug use.

Authors :
Christodoulou MC
Constantinou MS
Louppis AP
Christou A
Stavrou IJ
Kapnissi-Christodoulou CP
Source :
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2023 Jul 05; Vol. 231, pp. 115412. Date of Electronic Publication: 2023 Apr 21.
Publication Year :
2023

Abstract

A quantitative analytical procedure was developed and validated by the use of Ultra- Performance Liquid Chromatography tandem Mass Spectrometry (UPLC-MS/MS) for the determination of Cannabidiol (CBD), Cannabinol (CBN), Δ <superscript>9</superscript> -Tetrahydrocannabinol (Δ <superscript>9</superscript> -THC), Cannabichromene (CBC), Cannabigerol (CBG) and 11-Nor- 9- Carboxy- Tetrahydrocannabinol (THC-COOH) in an unconventional biological matrix, cerumen. All the investigated calibration curves were characterized by high correlation values (R <superscript>2</superscript> ≥ 0.9965). The LODs and LOQs ranged from 0.004 to 0.009 μg g <superscript>-1</superscript> and 0.012-0.029 μg g <superscript>-1</superscript> , respectively. Intra-assay and inter-assay precision were found to be 0.6-2.5%, and 0.8-2.2%, respectively. All recovery values of cannabinoids, with the use of the optimum cotton swab, at low (0.008 μg g <superscript>-1</superscript> of cerumen), medium (0.037 μg g <superscript>-1</superscript> of cerumen) and high (0.16 μg g <superscript>-1</superscript> of cerumen) control levels, were estimated to be above 86%. The method developed here permitted the analysis of real cerumen samples obtained from fourteen cannabis users. In twelve out of fourteen cases, Δ <superscript>9</superscript> -THC was found to be positive, while in six cases, three major cannabinoids, CBN, CBG and Δ <superscript>9</superscript> -THC were quantified at concentrations 0.02-0.21 μg g <superscript>-1</superscript> , 0.01-0.24 μg g <superscript>-1</superscript> and 0.01-4.86 μg g <superscript>-1</superscript> , respectively. Subject #8 has the highest amount of the detected substances in both left and right ear, with Δ <superscript>9</superscript> -THC at a concentration of 1.85 and 4.86 μg g <superscript>-1</superscript> , CBG 0.06 and 0.24 μg g <superscript>-1</superscript> , CBN 0.10 and 0.21 μg g <superscript>-1</superscript> , respectively. In addition, a detection window for the substances Δ <superscript>9</superscript> -Tetrahydrocannabinol, Cannabinol and Cannabigerol, in cerumen, was defined with success. In this case, Δ <superscript>9</superscript> -THC reached a maximum detection frame of up to fifteen days after smoking 0.5 g of marijuana cigarette. ANOVA-one-way analysis also indicated that the average earwax production of non-cannabis users differs significantly from the one of cannabis users (p = 0.048, <0.05). On the other hand, no significant difference was noticed between male and female users as the p value exceeded 0.05. In addition, no significant effect was observed on earwax production in regard to age, frequency and the last time of use (p > 0.05). These last three factors proved to have a significant impact on cannabinoids concentrations, since p values were less than 0.05.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2023 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-264X
Volume :
231
Database :
MEDLINE
Journal :
Journal of pharmaceutical and biomedical analysis
Publication Type :
Academic Journal
Accession number :
37087774
Full Text :
https://doi.org/10.1016/j.jpba.2023.115412